Science is moving closer than ever to making aging a reversible process. Researchers at Harvard University, led by geneticist David Sinclair, are testing a groundbreaking technique that could rejuvenate human cells and tissues. Clinical trials in humans are expected to begin in 2025, following highly promising results in animal studies. The findings have positioned this therapy as one of the most anticipated breakthroughs in modern medicine. How the Therapy Works The method developed by Sinclair and his team is based on a new idea:…